Skip to content
Search

Latest Stories

Top Stories

Three major health care battles taking shape in 2024

People protesting Dobbs decision

People protested on the first anniversary of the Supreme Court's June 2022 decision in the Dobbs case. The court may further limit abortion rights this year.

Celal Gunes/Anadolu Agency via Getty Images

Pearl is a clinical professor of plastic surgery at the Stanford University School of Medicine and is on the faculty of the Stanford Graduate School of Business. He is a former CEO of The Permanente Medical Group.

Modern medicine, for most of its history, has operated within a collegial environment — an industry of civility where physicians, pharmaceutical companies and hospitals stayed in their lanes and out of each other’s business.

Times have changed as health care has taken a 180-degree turn. This year will be characterized by cutthroat competition and intense disputes played out in public. And as the once harmonious world of health care braces for battle, three critical struggles take center stage. Each promises controversy and profound implications for the future of medicine.

The first battle involves abortion rights.


For nearly 50 years — from the landmark Roe v. Wade decision in 1973 to its overruling by the 2022 Dobbs case — abortion decisions were the province of women and their doctors. This dynamic has changed in nearly half the states.

This spring, the Supreme Court is set to hear another pivotal case. It concerns mifepristone, an important drug for medical abortions. The ruling, expected in June, will significantly impact women’s rights, as well as federal regulatory bodies like the Food and Drug Administration.

Sign up for The Fulcrum newsletter

Traditionally, abortions were surgical procedures. Today, over half are medically induced, primarily using a two-drug combination that includes mifepristone. Since its approval in 2000, mifepristone has been prescribed to over 5 million women, and it boasts an excellent safety record.

But anti-abortion groups have proposed stringent legal restrictions: reducing the administration window from 10 to seven weeks post-conception, banning distribution of the drug by mail, and mandating three in-person doctor visits, a burdensome requirement for many.

While physicians would still be allowed to prescribe misoprostol (the second drug in the regimen), its effectiveness alone pales in comparison to the two-drug combo.

Should the Supreme Court overrule the FDA’s clinical expertise on these matters, abortion activists fear the floodgates will open, inviting new challenges against other established medications like birth control.

In response, several states have fortified abortion rights through ballot initiatives, a trend expected to gain momentum in the November elections. This legislative action underscores a significant public-opinion break from the Supreme Court’s stance. In fact, a survey published in Nature Human Behavior reveals that 60 percent of Americans support legal abortion.

Who will win this battle? That’s unclear. Traditionally, the court’s rulings have mirrored public opinion on key social issues, but the gap is large on abortion rights. This sets the stage for an even fiercer clash in years to come. A Supreme Court ruling that renders abortion unconstitutional would contradict the principles outlined in Dobbs and recent protections passed by the states. As a result, America’s divide on abortion rights is poised to deepen.

The second battle involves the use of generative AI in medicine.

A year after ChatGPT’s release, artificial intelligence is already reshaping entire industries. In health care, insurers are leveraging AI to speed up and intensify claim denials, prompting providers to counter with AI-assisted appeals.

Beyond corporate skirmishes, the most profound AI conflict involves the doctor-patient relationship. Physicians, already vexed by patients who self-diagnose with “Dr. Google,” find themselves unsure whether generative AI will be friend or foe.

Studies conclude that generative AI can already diagnose and recommend treatments with remarkable accuracy and empathy, surpassing human doctors in ever-more ways. And unlike traditional search engines, generative AI doesn’t just spit out unfiltered, generic information. It provides nuanced and personalized insights based on terabytes of up-to-date medical research and the patient’s own health data.

Who will win this battle? Whoever embraces these tools faster and more intelligently. While doctors are already taking advantage of AI’s administrative benefits (billing, notetaking and data entry), they’re apprehensive that ChatGPT will lead to errors if used for patient care. But five years from now, with ChatGPT predicted to be 30 times more powerful, generative AI systems will become safer, more reliable and integral to medical care. Advanced tools, interfacing with wearables and electronic health records, will aid with disease management, diagnosis and chronic-condition monitoring, enhancing clinical outcomes, and overall health.

The final battle features a tug-of-war over health care pricing.

From routine doctor visits to complex hospital stays and drug prescriptions, every aspect of U.S. health care is getting more expensive. That’s not news to most Americans, half of whom say it is very or somewhat difficult to afford health care costs.

Throughout U.S. health care, financial pressures are increasing. Hospitals are consolidating. Nurses are striking. And thousands of physicians have sold their medical practices to private equity firms.

This trend will continue in 2024 and likely drive up prices, as much as 30 percent higher for many specialties.

Drug spending, meanwhile, will soar in 2024 as weight-loss drugs (costing roughly $12,000 a year) become increasingly available. A groundbreaking sickle cell disease treatment is projected to cost nearly $3 million upon release. This year, Big Pharma will bolster its efforts to delay or overturn legislation that would allow the centers for Medicare & Medicaid Services to negotiate prices for 10 of the most expensive outpatient drugs starting in 2026.

Who will win the pricing battle? That’s up to voters. With national health care spending expected to rise from $4 trillion now to $7 trillion by 2031, the upcoming election will be pivotal in steering the financial strategy. A Republican surge could mean tighter controls on Medicare and Medicaid and relaxed insurance regulations, whereas a Democratic sweep could lead to increased taxes, especially on the wealthy. A divided government, however, would stall significant reforms, exacerbating the crisis of unaffordability.

So, is peace possible? Amid the strife, hope glimmers: The rise of ChatGPT and other generative AI technologies holds promise for empowering patients and improving clinical outcomes. The debate over abortion rights, while deeply polarizing, might eventually find resolution in a legislative middle ground that echoes Roe’s protections with some restrictions on how late in pregnancy procedures can be performed.

Unfortunately, some problems need to get worse before they can get better. I predict the affordability of health care will be one of them. My New Year’s request is to not shoot the messenger.

Read More

While Pledging To Clean Up Toxic Chemicals, EPA Guts Hundreds of Environmental Grants

EPA Administrator Zeldin speaks with reporters on Long Island, NY.

Courtesy EPA via Flickr.

While Pledging To Clean Up Toxic Chemicals, EPA Guts Hundreds of Environmental Grants

WASHINGTON – The Trump administration promised to combat toxic “forever chemicals,” while conversely canceling nearly 800 grants aimed at addressing environmental injustices, including in communities plagued with PFAS contamination.

In a court filing, the Environmental Protection Agency revealed for the first time that it intends to cancel 781 environmental justice grants, nearly double what had previously been disclosed.

Keep ReadingShow less
Policy Changes Could Derail Michigan’s Clean Energy Goals

New clean energy manufacturing plants, including for EV batteries, solar panels, and wind turbines, are being built across states like Michigan, Georgia, and Ohio.

Steve/Adobe Stock

Policy Changes Could Derail Michigan’s Clean Energy Goals

In recent years, Michigan has been aggressive in its approach to clean energy: It’s invested millions of dollars in renewable energy infrastructure, created training programs for jobs in the electric vehicle industry, and set a goal of moving the state to 100% carbon neutrality by 2050.

Gov. Gretchen Whitmer and other state officials aim to make the Great Lakes State a leader in clean energy manufacturing by bringing jobs and investments to local communities while also tackling pollution, which continues to wreak havoc on the environment.

Now Michigan’s clean energy efforts have seemingly hit a wall of uncertainty as President Donald Trump’s administration takes ongoing actions to roll back federal climate regulations.

“We’ve seen nothing less than an unprecedented, all-out assault on our environment and our democracy,” said Bentley Johnson, the Michigan League of Conservation Voters’ federal government affairs director.

The clean energy sector has grown rapidly in the United States since President Joe Biden signed the Inflation Reduction Act in 2022. Congress appropriated $370 billion under the IRA, and White House officials at the time touted it as the country’s largest investment in clean energy.

According to Climate Power, a national public relations and advocacy organization dedicated to climate justice, Michigan was the No. 1 state in the nation in 2024 in its number of clean energy projects; from 2022-2024, the state announced 74 projects totalling over 26,000 jobs and roughly $27 billion in federal funding.

Trump has long been critical of the country’s climate initiatives and development of clean energy technology. He’s previously made false claims that climate change is a hoax and wind turbines cause cancer. Since taking office again in January, Trump has tried to pause IRA funding and signed an executive order to boost coal production.

Additionally, U.S. Environmental Protection Agency Administrator Lee Zeldin announced in March that the agency had canceled more than 400 environmental justice grants to be used to improve air and water quality in disadvantaged communities. Senate Democrats, who released a full list of the canceled grants, accused the EPA of illegally terminating the contracts, through which funds were appropriated by Congress under the IRA. Of those 400 grants, 15 were allocated for projects in Michigan, including one to restore housing units in Kalamazoo and another to transform Detroit area food pantries and soup kitchens into emergency shelters for those in need.

Johnson said the federal government reversing course on the allotted funding has left community groups who were set to receive it in the lurch.

“That just seems wrong, to take away these public benefits that there was already an agreement — Congress has already appropriated or committed to spending this, to handing this money out, and the rug is being pulled out from under them,” Johnson said.

Climate Power has tracked clean energy projects across the country totaling $56.3 billion in projected funding and over 50,000 potential jobs that have been stalled or canceled since Trump was elected in November. Michigan accounts for seven of those projects, including Nel Hydrogen’s plans to build an electrolyzer manufacturing facility in Plymouth.

Nel Hydrogen announced an indefinite delay in the construction of its Plymouth factory in February 2025. Wilhelm Flinder, the company’s head of investor relations, communications, and marketing, cited uncertainty regarding the IRA’s tax credits for clean hydrogen production as a factor in the company’s decision, according to reporting by Hometownlife.com. The facility was expected to invest $400 million in the local community and to create over 500 people when it started production.

“America is losing nearly a thousand jobs a day because of Trump’s war against cheaper, faster, and cleaner energy. Congressional Republicans have a choice: get in line with Trump’s job-killing energy agenda or take a stand to protect jobs and lower costs for American families,” Climate Power executive director Lori Lodes said in a March statement.

Opposition groups make misleading claims about the benefits of renewable energy, such as the reliability of wind or solar energy and the land used for clean energy projects, in order to stir up public distrust, Johnson said.

In support of its clean energy goals, the state fronted some of its own taxpayer dollars for several projects to complement the federal IRA money. Johnson said the strategy was initially successful, but with sudden shifts in federal policies, it’s potentially become a risk, because the state would be unable to foot the bill entirely on its own.

The state still has its self-imposed clean energy goals to reach in 25 years, but whether it will meet that deadline is hard to predict, Johnson said. Michigan’s clean energy laws are still in place and, despite Trump’s efforts, the IRA remains intact for now.

“Thanks to the combination — I like to call it a one-two punch of the state-passed Clean Energy and Jobs Act … and the Inflation Reduction Act, with the two of those intact — as long as we don’t weaken it — and then the combination of the private sector and technological advancement, we can absolutely still make it,” Johnson said. “It is still going to be tough, even if there wasn’t a single rollback.”

Sign up for The Fulcrum newsletter

Keep ReadingShow less
A Missed Opportunity

Broken speech bubbles.

Getty Images, MirageC

A Missed Opportunity

en español

In a disappointing turn of events, Connecticut has chosen to follow the precedent set by President Donald Trump’s English-Only Executive Order, effectively disregarding the federal mandates of Title VI of the 1964 Civil Rights Act.

Keep ReadingShow less
World Vaccine Congress Washington Tackles Anti-Vaccine Rhetoric in U.S. Politics

The World Vaccine Congress Washington is held at the Walter E. Washington Convention Center, April 23, 2025

(Erin Drumm/Medill New Service)

World Vaccine Congress Washington Tackles Anti-Vaccine Rhetoric in U.S. Politics

WASHINGTON—A vaccine policy expert challenged attendees of the World Vaccine Congress Washington to imagine a deadly disease spreading in various places around the country. We have the tools to stop it, but lawmakers were instead debating whether or not to use them.

In fact, that describes what is currently happening across the United States, according to Rehka Lakshmanan, M.H.A.

Keep ReadingShow less